Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First Investor R&D Day on March 14, 2016 … amaurosis (LCA), today presents an update on the innovation pipeline and announces an R&D day for investors. …
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.
… oligonucleotides for severe genetic diseases through our innovation unit.” Financial Highlights At June 30, 2016, … preclinical development of QR-110 and progress of our innovation programs such as QR-313 for epidermolysis bullosa, …
